Tech Center 1600 • Art Units: 1636 1637 1699
This examiner grants 58% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18425219 | RNA-Guided Transcriptional Regulation | Non-Final OA | President and Fellows of Harvard College |
| 16989119 | Large Gene Excision and Insertion | Non-Final OA | President and Fellows of Harvard College |
| 19303600 | CAS12 PROTEINS AND USES THEREOF | Non-Final OA | ZHEJIANG SYNSORBIO TECHNOLOGY CO., LTD. |
| 16625207 | Tropism-Modified Recombinant Viral Particles and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18303533 | SITE SPECIFIC GENETIC ENGINEERING UTILIZING TRANS-TEMPLATE RNAS | Non-Final OA | Massachusetts Institute of Technology |
| 17807405 | Compositions, Methods and Systems for the Delivery of Gene Editing Material to Cells | Final Rejection | Massachusetts Institute of Technology |
| 17631240 | COMPOSITIONS AND METHODS FOR TREATING ALPHA THALASSEMIA | Non-Final OA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 18308530 | ENHANCEMENT OF SAFETY AND PRECISION FOR CRISPR-Cas INDUCED GENE EDITING BY VARIANTS OF DNA POLYMERASE USING CAS-PLUS VARIANTS | Non-Final OA | New York University |
| 18392854 | COMPOSITIONS COMPRISING A LECITHIN CHOLESTEROL ACYLTRANSFERASE VARIANT AND USES THEREOF | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18322675 | SYSTEMS, METHODS, AND COMPOSITIONS FOR RNA-GUIDED RNA-TARGETING CRISPR EFFECTORS | Non-Final OA | The University of Tokyo |
| 18247157 | MARF/MFN MODULATORS AND USES THEREOF | Non-Final OA | University of Massachusetts |
| 18498448 | COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION | Final Rejection | Janssen Pharmaceuticals, Inc. |
| 18295387 | CRISPR/CAS9 COMPLEX FOR GENOMIC EDITING | Non-Final OA | THE UAB RESEARCH FOUNDATION |
| 17911130 | GENE INTERFERENCE VECTOR- AND IRON NANOPARTICLE-BASED COMPOSITION FOR KILLING CANCER CELLS, AND USE THEREOF | Non-Final OA | SOUTHEAST UNIVERSITY |
| 18658840 | YEAST STRAINS WITH SELECTED OR ALTERED MITOTYPES AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17782897 | CLINICAL DECISION SUPPORT FOR PERSONALIZED ADAPTIVE PROSTATE CANCER THERAPY | Final Rejection | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18220070 | PREVENTION OR TREATMENT OF WASTING SYNDROME | Non-Final OA | City of Hope |
| 18424838 | DUAL-FUNCTIONAL COSMETIC COMPOSITION AND PREPARING METHOD THEREOF | Non-Final OA | UBIPROTEIN CORP |
| 17821356 | CLOSED-END DNA PRODUCTION WITH INVERTED TERMINAL REPEAT SEQUENCES | Final Rejection | BIOVERATIV THERAPEUTICS INC. |
| 17776993 | Method for Detecting Undifferentiated Cells | Final Rejection | Eiken Kagaku Kabushiki Kaisha |
| 18307000 | COMPOSITIONS AND METHODS FOR MODULATING GENE TRANSCRIPTION NETWORKS | Final Rejection | Nuclear RNA Networks, Inc. |
| 18006075 | BIOMARKER SPECIFIC FOR LIVER CANCER, AND USE THEREOF | Non-Final OA | NEORNAT |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy